EP3917538
Deoxýsýtídínafleiður til notkunar við krabbameinsmeðferðir
:
EP einkaleyfi í gildi á Íslandi:
3.2.2020:
12.7.2023:
20703447.1
:
9.8.2023:
15.9.2023
:
2.2.2040:
2.2.2026:
28.2.2026
:
DEOXY- CYTIDINE DERIVATIVES FOR USE IN CANCER THERAPIES
3.2.2020
12.7.2023
9.8.2023
15.9.2023
2.2.2026
:
Hemispherian AS:
Lørenveien 73A, 0585 Oslo, NO
:
ROBERTSON, Adam Brian:
0585 Oslo, NO
:
PRIKRYLOVA, Terezia:
0585 Oslo, NO
:
G.H. Sigurgeirsson ehf.:
Borgartúni 26, 105, Reykjavík,
:
201901427:
1.2.2019:
GB
:
EP2020052632:
3.2.2020
:
A61K 31/7068, A61K 31/7072, A61K 45/06, A61P 35/00
: 5
: 16.2.2024
: 2.2.2025
: CPA Global (Patrafee) AB
: 6
: 24.3.2025
: 2.2.2026
: CPA Global (Patrafee) AB